erik gatenholm

Big Changes at BICO: Founders Leave as Whistleblower Revelations Spark Overhaul

In a significant development at BICO (STO: BICO), founders Erik Gatenholm and Hector Martinez have decided to leave the company after eight years, marking the end of an era for…

Featured

BICO’s Revival: A Fresh Era with Maria Forss at the Helm

Swedish biotech company BICO (STO: BICO) has been making waves in the industry recently. Ever since Maria Forss assumed the role of CEO in November 2023, the company seems to…

Featured

BICO’s Path to Profitability is A Test for New CEO Maria Forss

Sharing two key announcements that could signal a new direction, bioscience and bioprinting firm BICO (STO: BICO) has appointed Maria Forss as its new President and CEO. As a demonstration…

Featured

Bioprinting’s Trouble in Paradise: BICO Tackles Management Issues After Co-Founder Resigns as CFO

On April 25, 2022, BICO (STO: BICO) co-founder Gusten Danielsson left his post as Chief Financial Officer (CFO) at the biotech corporation. Just hours later, he gave an explosive interview…

Featured

Cellink: Can This Bioprinting Firm Reach a $10B Valuation?

Since 2019, bioprinting pioneer Cellink (OTC: CCLKF / CLNK-B.ST) has gone from a $257 million market capitalization to a $1.5 billion-plus valuation. Before it went public in 2016, this new…

CELLINK’s New Bioprinting Platform for Complex Structures, the Bio X6

CELLINK announced the latest product in their line of specialized bioprinting technology, the newly designed BIO X6, which can leverage up to six different intelligent printheads to fabricate constructs with…

CELLINK to Acquire German Startup cytena for 30 Million Euros

Bioprinting company CELLINK announced it has entered into an agreement with the owners of life science company cytena GmbH, of Germany, to acquire all of the company shares for a purchase…

Cellink Turns to 3D Printing Tumors to Combat Cancer

It may seem counterintuitive, but the Swedish biotech company Cellink is actually fabricating tumors in an effort to combat cancer. The company, which exploded on the scene in 2016, has…